Neuro-Oncology: The Podcast

88 Episodes

1. Pre-operative [11C]methionine PET for low-grade glioma

   Published: 16/12/2022
2. The role of T lymphocytes in the glioma pathobiology

   Published: 02/12/2022
3. CDKN2A homozygous deletion in IDH mutant astrocytoma

   Published: 08/10/2022
4. EGFR: the lazarus target in glioblastom

   Published: 23/09/2022
5. Brain metastases; a SNO consensus review: Part 2

   Published: 09/09/2022
6. Brain metastases; a SNO consensus review: Part 1

   Published: 26/08/2022
7. Pediatric IDH mutant gliomas

   Published: 13/08/2022
8. Low-risk meningioma: Outcomes from NRG 0539

   Published: 29/07/2022
9. Selumetinib in children with NF1 and plexiform neurofibroma

   Published: 01/07/2022
10. Targeted therapy for BRAF-mutant pediatric glioma

    Published: 17/06/2022
11. Early/evolving IDH wild-type glioblastoma

    Published: 20/05/2022
12. PI3K signaling in IDH mutant gliomas

    Published: 06/05/2022
13. Cell-free DNA from CSF in pediatric, adolescent and young adult patients

    Published: 22/04/2022
14. Molecular determinants of neurocognitive deficits in glioma

    Published: 08/04/2022
15. H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

    Published: 25/03/2022
16. Clinical trial accrual for women and minorities in neuro-oncology

    Published: 11/03/2022
17. The clinical utility of next generation sequencing for IDHwt glioblastoma

    Published: 11/02/2022
18. Trabectedin for recurrent grade 2 or 3 meningiomas

    Published: 28/01/2022
19. Glioblastoma cell heterogeneity and plasticity

    Published: 14/01/2022
20. Moleculary integrated grading for meningioma

    Published: 24/12/2021